Methods and kits for diagnosing obstructive sleep apnea
AssigneeUniversity of Louisville Research Foundation, Inc.
InventorsDavid Gozal, Saeed A. Jortani, Roland Valdes, JR., Leila Kheirandish-Gozal
Life of this patent
Estimating the term…
Abstract
The presently-disclosed subject matter provides methods and kits for diagnosing obstructive sleep apnea (OSA) in a subject, such as a human child, wherein a biological sample is provided from the subject and the amount of a Urocortin III peptide is determined from the sample. Further provided are methods for diagnosing OSA in a subject wherein the amount of a Urocortin III peptide and one or more peptides selected from a Uromodulin peptide, an Orosomucoid 1 peptide, and a Kallikrein 1 peptide are determined in a biological sample from a subject.
Claims27
A method for diagnosing obstructive sleep apnea in a subject, comprising:
- (a) providing a biological sample from the subject;
- (b) determining an amount in the sample of a Urocortin III peptide;
- and
- (c) comparing the amount of the Urocortin III peptide in the sample, if present, to a control level of the Urocortin III peptide, wherein the subject is diagnosed as having obstructive sleep apnea if there is a measurable difference in the amount of the Urocortin III peptide in the sample as compared to the control level.
A method for determining whether to initiate or continue prophylaxis or treatment of obstructive sleep apnea in a subject, comprising:
- (a) providing a series of biological samples over a time period from the subject;
- (b) analyzing the series of biological samples to determine an amount in each of the biological samples of a Urocortin III peptide;
- and
- (c) comparing any measurable change in the amounts of the Urocortin III peptide in each of the biological samples to thereby determine whether to initiate or continue the prophylaxis or therapy of the obstructive sleep apnea.
A kit for diagnosing obstructive sleep apnea in a subject, the kit comprising one or more antibodies capable of detecting a Urocortin III peptide in a biological sample obtained from a subject and instructions for using the kit.
Dependencies are inferred from the claim text.